Cargando…
The effect of hemoperfusion on the outcome, clinical and laboratory findings of patients with severe COVID-19: a retrospective study
Hemoperfusion is a method of blood filtering to remove toxins and inflammatory factors. Cytokine storms and high levels of inflammatory factors play a role in the pathogenesis of coronavirus disease 2019 (COVID-19). The present study aims to evaluate the effect of hemoperfusion on the clinical and l...
Autores principales: | Soleimani, A., Taba, S.M. Moeini, Hasibi Taheri, S., Loghman, A.H., Shayestehpour, M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8410636/ https://www.ncbi.nlm.nih.gov/pubmed/34490065 http://dx.doi.org/10.1016/j.nmni.2021.100937 |
Ejemplares similares
-
Systemic lupus erythematosus manifestation following COVID-19: a case report
por: Zamani, Batool, et al.
Publicado: (2021) -
The occurrence of Adrenocorticotropic hormone-independent Cushing's syndrome in a woman with the history of papillary thyroid carcinoma: a case report
por: Tabatabaizadeh, Mashallah, et al.
Publicado: (2021) -
Re-evaluation of direct hemoperfusion with polymyxin-B immobilized fiber for severe sepsis and septic shock
por: Matsuo, SM, et al.
Publicado: (2011) -
69: COMPARING THE OUTCOMES OF GIVING TOCILIZUMAB THEN HEMOPERFUSION, HEMOPERFUSION THEN TOCILIZUMAB, AND NO INTERVENTION IN CRITICAL SARS-COV-2 PNEUMONIA PATIENTS IN MAKATI MEDICAL CENTER
por: Macatangay, M.V.R., et al.
Publicado: (2022) -
Hemoperfusion in patients with severe COVID-19 respiratory failure, lifesaving or not?
por: Abbasi, Saeed, et al.
Publicado: (2021)